The Personalised Breast Cancer Programme in Cambridge is pioneering ways to tackle hard-to-treat breast cancer.
Rachel, from East Sussex, shares how her sister Thekla’s breast cancer diagnosis has affected the family so far.
New computer simulation study suggests only screening women deemed at a ‘high risk’ of breast cancer could help to reduce unnecessary diagnoses.
In the immediate aftermath, estimating the numbers affected by a breast screening error might do more harm than good.
With new cancer detection technology on the horizon, ranging from blood tests to wristbands, understanding overdiagnosis is a huge challenge.
Our researchers have discovered a way to halt breast cancer spread in mice, by blocking a molecule called asparagine. But what does this mean for patients?
The START trials provided the evidence needed to change practice for women having radiotherapy to treat breast cancer.
A world-first data report could help us understand whether cancer patients are getting the most appropriate treatments for them.